Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii

ABSTRACTAcinetobacter baumannii emerged as one of the most important pathogens that causes nosocomial infections due to its increased multidrug resistance. Identifying capsular epidemiology in A. baumannii can aid in the development of effective treatments and preventive measures against this emergi...

Full description

Bibliographic Details
Main Authors: Yu-Chia Hsieh, Shi-Heng Wang, Yi-Yin Chen, Tzu-Lung Lin, Shian-Sen Shie, Ching-Tai Huang, Chen-Hsiang Lee, Yi-Ching Chen, Tran Lam Tu Quyen, Yi-Jiun Pan
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1822757
_version_ 1827320728625610752
author Yu-Chia Hsieh
Shi-Heng Wang
Yi-Yin Chen
Tzu-Lung Lin
Shian-Sen Shie
Ching-Tai Huang
Chen-Hsiang Lee
Yi-Ching Chen
Tran Lam Tu Quyen
Yi-Jiun Pan
author_facet Yu-Chia Hsieh
Shi-Heng Wang
Yi-Yin Chen
Tzu-Lung Lin
Shian-Sen Shie
Ching-Tai Huang
Chen-Hsiang Lee
Yi-Ching Chen
Tran Lam Tu Quyen
Yi-Jiun Pan
author_sort Yu-Chia Hsieh
collection DOAJ
description ABSTRACTAcinetobacter baumannii emerged as one of the most important pathogens that causes nosocomial infections due to its increased multidrug resistance. Identifying capsular epidemiology in A. baumannii can aid in the development of effective treatments and preventive measures against this emerging pathogen. Here we established a wzc-based method, and combined it with wzy-PCR to determine capsular types of A. baumannii causing nosocomial bacteraemia collected at two medical centres in Taiwan from 2015 to 2017. Among the 237 patients with A. baumannii bacteraemia, 98 (41.4%) isolates were resistant to carbapenems. Four prevalent capsular types (KL2, KL10, KL22, and KL52) accounted for 84.7% of carbapenem-resistant A. baumannii (CRAB) and 12.2% of non-CRAB. The rate of pneumonia, intensive care unit admission, APACHE II score, and Pitt bacteraemia score were higher in patients with KL2/10/22/52 infection than in those with non-KL2/10/22/52 infection. Patients with KL2/10/22/52 infection and patients with CRAB infection have a higher cumulative incidence of attributable and all-cause in-hospital 30-day mortality. On multivariate analysis, appropriate empirical antimicrobial therapy within 24 h was associated with a lower risk of 30-day attributable mortality in the KL2/10/22/52 isolates (odds ratio = 0.19, 95% CI: 0.06–0.66, p = 0.008) but not in non-KL2/10/22/52 isolates. Early recognition of carbapenem resistance-associated capsular types may help clinicians to promptly implement appropriate antimicrobial therapy for improving the outcomes in patients with CRAB bacteraemia.
first_indexed 2024-03-07T17:24:36Z
format Article
id doaj.art-e83b9d99cd0041ec8a11b1b878ce07b4
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2024-04-25T00:52:15Z
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-e83b9d99cd0041ec8a11b1b878ce07b42024-03-11T16:04:23ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512020-01-01912094210410.1080/22221751.2020.1822757Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumanniiYu-Chia Hsieh0Shi-Heng Wang1Yi-Yin Chen2Tzu-Lung Lin3Shian-Sen Shie4Ching-Tai Huang5Chen-Hsiang Lee6Yi-Ching Chen7Tran Lam Tu Quyen8Yi-Jiun Pan9Department of Pediatrics, Chang Gung Children’s Hospital, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, TaiwanDepartment of Occupational Safety and Health and Public Health, College of Public Health, China Medical University, Taichung, TaiwanDepartment of Pediatrics, Chang Gung Children’s Hospital, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, TaiwanDepartment of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taoyuan, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taoyuan, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital – Kaohsiung Medical Center, Chang Gung University, Kaohsiung, TaiwanDepartment of Pediatrics, Chang Gung Children’s Hospital, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, TaiwanDepartment of Microbiology and Immunology, School of Medicine, College of Medicine, China Medical University, Taichung, TaiwanDepartment of Microbiology and Immunology, School of Medicine, College of Medicine, China Medical University, Taichung, TaiwanABSTRACTAcinetobacter baumannii emerged as one of the most important pathogens that causes nosocomial infections due to its increased multidrug resistance. Identifying capsular epidemiology in A. baumannii can aid in the development of effective treatments and preventive measures against this emerging pathogen. Here we established a wzc-based method, and combined it with wzy-PCR to determine capsular types of A. baumannii causing nosocomial bacteraemia collected at two medical centres in Taiwan from 2015 to 2017. Among the 237 patients with A. baumannii bacteraemia, 98 (41.4%) isolates were resistant to carbapenems. Four prevalent capsular types (KL2, KL10, KL22, and KL52) accounted for 84.7% of carbapenem-resistant A. baumannii (CRAB) and 12.2% of non-CRAB. The rate of pneumonia, intensive care unit admission, APACHE II score, and Pitt bacteraemia score were higher in patients with KL2/10/22/52 infection than in those with non-KL2/10/22/52 infection. Patients with KL2/10/22/52 infection and patients with CRAB infection have a higher cumulative incidence of attributable and all-cause in-hospital 30-day mortality. On multivariate analysis, appropriate empirical antimicrobial therapy within 24 h was associated with a lower risk of 30-day attributable mortality in the KL2/10/22/52 isolates (odds ratio = 0.19, 95% CI: 0.06–0.66, p = 0.008) but not in non-KL2/10/22/52 isolates. Early recognition of carbapenem resistance-associated capsular types may help clinicians to promptly implement appropriate antimicrobial therapy for improving the outcomes in patients with CRAB bacteraemia.https://www.tandfonline.com/doi/10.1080/22221751.2020.1822757Acinetobacter baumanniicapsular typeserotypetyping systemcarbapenem resistance
spellingShingle Yu-Chia Hsieh
Shi-Heng Wang
Yi-Yin Chen
Tzu-Lung Lin
Shian-Sen Shie
Ching-Tai Huang
Chen-Hsiang Lee
Yi-Ching Chen
Tran Lam Tu Quyen
Yi-Jiun Pan
Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
Emerging Microbes and Infections
Acinetobacter baumannii
capsular type
serotype
typing system
carbapenem resistance
title Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
title_full Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
title_fullStr Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
title_full_unstemmed Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
title_short Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
title_sort association of capsular types with carbapenem resistance disease severity and mortality in acinetobacter baumannii
topic Acinetobacter baumannii
capsular type
serotype
typing system
carbapenem resistance
url https://www.tandfonline.com/doi/10.1080/22221751.2020.1822757
work_keys_str_mv AT yuchiahsieh associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii
AT shihengwang associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii
AT yiyinchen associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii
AT tzulunglin associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii
AT shiansenshie associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii
AT chingtaihuang associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii
AT chenhsianglee associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii
AT yichingchen associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii
AT tranlamtuquyen associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii
AT yijiunpan associationofcapsulartypeswithcarbapenemresistancediseaseseverityandmortalityinacinetobacterbaumannii